Aia Group LTD Abiomed Inc Transaction History

Aia Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$242.49 - $301.46 $33,706 - $41,902	-139 Reduced 2.37%	5,723 $1.41 Million
Q2 2022 Aug 11, 2022	SELL	$224.73 - $338.64 $199,784 - $301,050	-889 Reduced 13.17%	5,862 $1.45 Million
Q1 2022 May 06, 2022	SELL	$277.25 - $366.29 $2.8 Million - $3.7 Million	-10,108 Reduced 59.96%	6,751 $2.24 Million
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $570,595 - $704,822	1,898 Added 12.69%	16,859 $6.06 Million
Q3 2021 Nov 05, 2021	BUY	$310.19 - $376.2 $900,791 - $1.09 Million	2,904 Added 24.09%	14,961 $4.87 Million
Q2 2021 Aug 03, 2021	BUY	$262.71 - $351.17 $345,200 - $461,437	1,314 Added 12.23%	12,057 $3.79 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $1.03 Million - $1.28 Million	3,618 Added 50.78%	10,743 $3.42 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $1.79 Million - $2.31 Million	7,125 New	7,125 $2.32 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.